Jiangsu Gensciences lnc. Report issue

For profit Phase 1 Phase 3
Founded: Jiangsu China (2020)

Organization Overview

First Clinical Trial
2020
NCT04456387
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Haimen Gensciences lnc | Jiangsu Gensciences lnc.